Sign in

CIK 0001434316

  • Non-accelerated filer
  • Smaller reporting company

FATE THERAPEUTICS INC

Sign in to watch
Ticker
FATE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
651311552
Phone
+1 858-875-1803
Business address
12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,525
in 1 filing

Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Adawi Kamal −$14K Chief Financial Officer sold 7% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-04-22 Wolchko J Scott President and CEO Sale −30,000 $85.54 $2.6M 393,793
2021-04-22 Wolchko J Scott President and CEO Option exercise · Stock Option (right to buy) −30,000 140,000
2021-04-16 Chu Yu-Waye Senior VP Clinical Development Sale −875 $81.80 $72K 67,200
2021-04-16 Chu Yu-Waye Senior VP Clinical Development Sale −900 $82.91 $75K 66,300
2021-04-16 Chu Yu-Waye Senior VP Clinical Development Sale −1,500 $84.41 $127K 64,800
2021-04-01 TAHL CINDY See Remarks Option exercise +28,149 $2.90 $82K 136,197
2021-04-01 TAHL CINDY See Remarks Option exercise +1,851 $7.87 $15K 138,048
2021-04-01 TAHL CINDY See Remarks Sale −1,000 $80.49 $80K 137,048
2021-04-01 TAHL CINDY See Remarks Sale −8,220 $81.48 $670K 128,828
2021-04-01 TAHL CINDY See Remarks Sale −4,556 $82.69 $377K 124,272
2021-04-01 TAHL CINDY See Remarks Sale −3,490 $83.40 $291K 120,782
2021-04-01 TAHL CINDY See Remarks Sale −2,200 $84.48 $186K 118,582
2021-04-01 TAHL CINDY See Remarks Sale −4,835 $85.98 $416K 113,747
2021-04-01 TAHL CINDY See Remarks Sale −5,299 $86.76 $460K 108,448
2021-04-01 TAHL CINDY See Remarks Sale −400 $87.45 $35K 108,048
2021-04-01 TAHL CINDY See Remarks Option exercise · Stock Option (Right to Buy) −28,149 0
2021-04-01 TAHL CINDY See Remarks Option exercise · Stock Option Right to Buy −1,851 10,458
2021-03-15 Valamehr Bahram Chief Development Officer Option exercise −25,000 $2.90 $73K 120,740
2021-03-15 Valamehr Bahram Chief Development Officer Sale −3,957 $90.89 $360K 116,783
2021-03-15 Valamehr Bahram Chief Development Officer Sale −8,416 $91.94 $774K 108,367

Page 21 of 26 · 503 trades